Unknown

Dataset Information

Construction of immune-related lncRNA signature to predict aggressiveness, immune landscape, and drug resistance of colon cancer.


ABSTRACT:

Background

Colon cancer remains one of the most common malignancies across the world. Thus far, a biomarker, which can comprehensively predict the survival outcomes, clinical characteristics, and therapeutic sensitivity, is still lacking.

Methods

We leveraged transcriptomic data of colon cancer from the existing datasets and constructed immune-related lncRNA (irlncRNA) pairs. After integrating with clinical survival data, we performed differential analysis and identified 11 irlncRNAs signature using Lasso regression analysis. We next plotted the 1-, 5-, and 10-year curve lines of receiver operating characteristics, calculated the areas under the curve, and recognized the optimal cutoff point. Then, we validated the pair-risk model in terms of the survival outcomes of the pat

SUBMITTER: Xue Y 

PROVIDER: S-EPMC8928673 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature